Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
‘People are always looking for a scapegoat’ : tensions rise in UK’s asylum and refugee hotspot
5/11/2025
Low-income areas in England and Wales face worst air pollution, analysis finds
5/11/2025
Economic policy is one thing Nigel Farage can’t crib from the Donald Trump playbook | Rafael Behr
5/11/2025
Mamdani’s victory is a rebuke to the failed strategies of the Democratic party | Moira Donegan
5/11/2025
‘A meeting of voices’ : flotillas head into Belém ahead of Cop30 climate summit
5/11/2025
‘I thought ‘Bond girl’ was such a demeaning term’ : Famke Janssen on acting, ambition and Woody Allen
5/11/2025